Inpharma Weekly

, Volume 1497, Issue 1, pp 10–10 | Cite as

Molecular characteristics not indicative of NSCLC survival

News item
  • 4 Downloads

Keywords

Lung Cancer Epidermal Growth Factor Receptor Erlotinib Placebo Recipient England Journal 

Copyright information

© Adis International Ltd 2005

Personalised recommendations